Iva Domjanovic-Klarica
Zagreb, 10000, Croatia
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 9 publications
ABCG2 Genetic Variability in Drug Exposure and Toxicity: Implications for Clinical Practice.
Journal: Toxics
Published: February 27, 2026
Breast cancer resistance protein polymorphism ABCG2 c.421C>A (rs2231142) moderates the effect of valproate on lamotrigine trough concentrations in adults with epilepsy.
Journal: Fundamental & clinical pharmacology
Published: December 21, 2022
ABCG2 and SLCO1B1 gene polymorphisms in the Croatian population.
Journal: Annals of human biology
Published: November 16, 2022
Use of pharmacogenomics in elderly patients treated for cardiovascular diseases.
Journal: Croatian medical journal
Published: May 08, 2020
Pharmacogenetics and the treatment of epilepsy: what do we know?
Journal: Pharmacogenomics
Published: October 08, 2019
Effect of antiepileptic drug comedication on lamotrigine concentrations.
Journal: Croatian medical journal
Published: March 03, 2018
Interaction between ABCG2 421C>A polymorphism and valproate in their effects on steady-state disposition of lamotrigine in adults with epilepsy.
Journal: British journal of clinical pharmacology
Published: November 17, 2017
Integrating Pharmacovigilance and Pharmacogenomics: Croatian Experience.
Journal: Clinical therapeutics
Published: September 28, 2016
The Role Of Cyp2d6, Cyp3a4/5, And Abcb1 Polymorphisms In Patients Using Long-Acting Injectable Risperidone.
Journal: Clinical therapeutics
Published: September 28, 2016
Showing 1-9 of 9
Last Updated: 09/26/2026